Investment Rating - The report maintains an "Overweight" rating for the non-bank financial sector [1] Core Views - The insurance and brokerage stocks are expected to see valuation recovery driven by high earnings growth [1] - The non-bank financial sector has shown a mixed performance, with insurance leading in growth, followed by diversified finance and securities [8][9] Summary by Sections Non-Bank Financial Subsector Performance - In the recent five trading days (October 20-24, 2025), all non-bank financial subsectors underperformed the CSI 300 index, with insurance up by 2.99%, diversified finance by 2.70%, and securities by 2.02% [8] - Year-to-date performance shows insurance leading with a 14.47% increase, followed by diversified finance at 12.38%, and brokerage at 7.73% [9] Non-Bank Financial Subsector Insights Securities - Trading volume has increased year-on-year, with October's average daily stock trading volume at CNY 25,070 billion, up 12.07% from last year [13] - Margin financing balance reached CNY 24,510 billion, a year-on-year increase of 47.76% [13] - The average price-to-book (PB) ratio for the securities industry is projected at 1.3x for 2025 [23] Insurance - Major insurers like China Life and New China Life are expected to report significant profit increases for Q3, with China Life's net profit projected between CNY 156.8 billion and CNY 177.7 billion, reflecting a 50%-70% year-on-year growth [25] - The insurance sector is benefiting from regulatory support for high-quality health insurance development [31] Diversified Finance - The trust industry is experiencing a stable transition, with total trust assets expected to reach CNY 29.56 trillion by the end of 2024, a 23.58% year-on-year increase [34] - The futures market saw a trading volume of 770 million contracts in September, with a transaction value of CNY 71.50 trillion, reflecting a 33.16% year-on-year growth [38] Industry Ranking and Key Company Recommendations - The non-bank financial sector is currently undervalued, presenting a safety margin for investors [34] - The recommended ranking for investment is insurance > securities > diversified finance, with key companies including China Ping An, New China Life, China Pacific Insurance, CITIC Securities, and Tonghuashun [34]

Investment Rating - The report maintains a "Positive" investment rating for the investment banking and brokerage industry [7] Core Insights - Recent market enthusiasm remains high, with Q3 brokerage performance expected to continue its growth trend. The long-term ROE central tendency is anticipated to rise. In the insurance sector, the logic of deposit migration, increased equity allocation, and improved new policy costs is confirmed, leading to greater certainty in long-term ROE improvement and accelerated valuation recovery. Overall, the cost-performance ratio for investment is gradually increasing [2][4] Summary by Sections Industry Performance - The non-bank financial index increased by 2.7% last week, with an excess return of 0.7% relative to the CSI 300. Year-to-date, the non-bank financial index is up 6.9%, but underperforms the CSI 300 by 11.0% [5][17] Market Activity - Market activity has slightly declined, with an average daily trading volume of 21,876.96 billion yuan, down 5.43% week-on-week. The average turnover rate is 2.28%, a decrease of 17.11 basis points [5][39] Insurance Sector - In August 2025, cumulative insurance premium income reached 479.99 billion yuan, a year-on-year increase of 9.63%. Life insurance premiums grew by 14.05%, while property insurance premiums increased by 4.67% [21][25] Brokerage Recommendations - The report recommends stable dividend-paying stocks such as Jiangsu Jinzhong, China Ping An, and China Pacific Insurance, along with companies like New China Life, China Life, Hong Kong Exchanges, CITIC Securities, Dongfang Wealth, and Tonghuashun based on performance elasticity and valuation [4][6] Financing Activities - In September 2025, equity financing reached 41.634 billion yuan, a month-on-month increase of 86.6%, while bond financing totaled 8.11 trillion yuan, up 8.3% [50]

Core Viewpoint - The Financial Regulatory Bureau has issued guidelines to promote the high-quality development of health insurance, addressing the increasing demand for health protection and the need for industry reform [1][2]. Group 1: Background and Rationale - Health insurance is crucial for providing financial protection against health-related losses and is integral to the social security system, linking healthcare and economic stability [1]. - The growing demand for health insurance is driven by economic development and the Health China strategy, highlighting the need for improved service levels and product diversity [1]. - Existing challenges include a lack of product variety, insufficient industry capabilities, and inadequate collaboration with the healthcare sector, which hinder service enhancement [1]. Group 2: Drafting Approach - The guidelines aim to clarify requirements for different segments of health insurance, expand product offerings, and support the development of floating income health insurance [2]. - Emphasis is placed on strengthening the industry's foundation, enhancing digital transformation, and improving data utilization [2]. - The guidelines encourage specialized operations within health insurance companies and promote collaboration with the health industry to improve the accessibility of innovative medical products [2]. Group 3: Main Content - The guidelines consist of five main parts: overall requirements, deepening health insurance reform, enhancing sustainable development capabilities, strengthening regulatory oversight, and optimizing the development environment [3][4]. - Specific focus areas include commercial medical insurance, long-term care insurance, income loss insurance, and disease insurance, with plans for regulatory standardization [3]. Group 4: Future Work Arrangements - The Financial Regulatory Bureau will coordinate with other departments to create a favorable policy environment for health insurance development [5]. - There will be a focus on developing detailed regulations for floating income health insurance and ensuring compliance with the guidelines to meet public demand for quality health protection [5]. - Regulatory efforts will be intensified to combat illegal activities and protect consumer rights in the health insurance sector [5].

Core Viewpoint - The Financial Regulatory Bureau has issued guidelines to promote the high-quality development of health insurance, focusing on optimizing existing policies and addressing key issues in the sector [1][2] Group 1: Development Focus - The guidelines outline development priorities for four major types of insurance: commercial medical insurance, long-term care insurance, income loss insurance due to disability, and disease insurance [1][3] - There is an emphasis on developing a comprehensive and multi-tiered commercial medical insurance product system, incorporating new medical technologies and treatments [3][5] - The guidelines support the development of floating income health insurance, indicating a potential resurgence of dividend-type critical illness insurance products [1][6] Group 2: Regulatory Measures - The Financial Regulatory Bureau plans to enhance communication with other departments to create a favorable policy environment for health insurance development [2] - There will be a focus on accelerating the research and implementation of supporting business details for floating income health insurance [2][6] - The guidelines stress the importance of strengthening regulatory oversight of health insurance businesses to protect consumer rights [2] Group 3: Integration and Collaboration - The guidelines advocate for the integration of health insurance with health management services, promoting a holistic approach to health risk reduction and improving public health [4][5] - There is support for establishing collaborative mechanisms with pharmaceutical and medical device companies to explore innovative payment methods based on market principles [4] Group 4: Product Diversification - The guidelines encourage the development of long-term care insurance and income loss insurance due to disability, aiming to meet the needs of home, community, and institutional care [5][6] - There is a call to enhance the definition of diseases covered by disease insurance in line with changes in disease patterns and medical advancements [6] - The guidelines propose to increase the core competitiveness of health insurance companies by exploring new business strategies and models [7]

Investment Rating - The report indicates a positive outlook for the health insurance industry, suggesting a potential increase in value exceeding 15% over the next 3-6 months [5]. Core Insights - The report emphasizes the importance of health insurance in the national health security system by 2030, as outlined in the recent regulatory guidance [1]. - It highlights the need for differentiated requirements across various segments of health insurance, with a focus on commercial medical insurance as a core growth area [2]. - The report advocates for the development of innovative insurance products that cater to specific groups, such as those with pre-existing conditions and rare diseases [2]. - It stresses the importance of collaboration among regulatory bodies, insurance organizations, and information-sharing platforms to enhance the health insurance ecosystem [3]. - The report outlines key future regulatory priorities, including the promotion of floating yield health insurance and the enhancement of health management services within insurance products [3]. Summary by Sections Commercial Medical Insurance - The report supports the active development of commercial medical insurance, which is expected to be a significant growth driver in the health insurance sector [2]. - It encourages the inclusion of new medical technologies and treatments in insurance coverage and the establishment of a pricing mechanism based on risk categories [2]. Disease Insurance - The report suggests a steady development approach for disease insurance, with a focus on supporting well-rated insurance companies in offering dividend-based long-term health insurance products [2]. Long-term Care Insurance - There is a call to accelerate the development of commercial long-term care insurance and income loss insurance due to disability [2]. Collaboration and Policy Support - The report emphasizes the need for enhanced cooperation between regulatory authorities and local governments to support the development of regional and specialized insurance products [3]. - It also highlights the importance of leveraging existing policies to promote group health insurance and facilitate quick claims processing in commercial medical insurance [3].

Investment Rating - The industry investment rating is "Overweight" (maintained) [1] Core Insights - The report highlights the significant potential for growth in the health insurance sector, driven by increasing health awareness and an aging population. The recent regulatory guidance aims to enhance the quality and scope of health insurance products [4][5] - Major insurance companies are strategically positioning themselves in the health management sector, which is expected to improve profitability and valuation as they leverage their comprehensive advantages [6] Summary by Sections Industry Overview - The health insurance market is projected to expand significantly due to demographic changes and rising health consciousness among the population [5] - The report notes a decline in the proportion of health insurance premiums in recent years, attributed to factors such as profitability of insurance products and market standardization [5] Regulatory Developments - The China Banking and Insurance Regulatory Commission issued guidelines to promote the high-quality development of health insurance, emphasizing the need for a multi-layered health insurance market by 2030 [4] - Key initiatives include expanding coverage to include new medical technologies and supporting the integration of health insurance with health management services [4][5] Company Strategies - Leading insurance firms like China Pacific Insurance, China Life, and Ping An are enhancing their health management capabilities and developing innovative insurance products [6] - These companies are expected to benefit from regulatory support, which will help them reduce risk and improve profitability through a higher proportion of health insurance in their portfolios [6]

Core Viewpoint - The recent issuance of the "Guiding Opinions on Promoting the High-Quality Development of Health Insurance" by the National Financial Supervision Administration aims to strengthen regulation and mitigate risks, aligning with the Healthy China strategy [2][4] Regulatory Developments - The guiding opinions set a target for health insurance to play a more significant role in the national health security system by 2030, promoting the coordinated development of group and individual health insurance [2][4] Market Dynamics - Market demand for savings remains strong, and with ongoing regulatory guidance and proactive transformation by insurance companies, liability costs are expected to gradually decrease, alleviating pressure from interest rate spreads [5] - The recent decline in the ten-year government bond yield to approximately 1.86% may ease the pressure on insurance companies' new fixed-income investment returns as the domestic economy recovers [5] Industry Performance - In the first eight months of 2025, total health insurance premiums reached 759.8 billion yuan, reflecting a year-on-year growth of 2.4%, accounting for about 20% of life insurance premiums [4] - The insurance sector's valuation as of September 30, 2025, is projected to be between 0.57-0.86 times PEV and 1.02-2.19 times PB, indicating that the industry is at a historical low and maintaining an "overweight" rating [5] Product Innovation and Collaboration - The guiding opinions encourage the development of various health insurance products, including commercial medical insurance, long-term care insurance, and disease insurance, while promoting collaboration between health insurance and the medical industry [3][4] - The reintroduction of dividend-type health insurance products is expected to enhance product attractiveness and stimulate market growth potential [4]

Core Viewpoint - The National Financial Regulatory Administration has issued guidelines to promote the high-quality development of health insurance, aligning with the "Healthy China" strategy and enhancing regulatory measures to mitigate risks in the insurance sector [1][2]. Overall Requirements - The guidelines emphasize the importance of health insurance in the national health security system by 2030, aiming for a multi-level health insurance market that meets diverse needs across the population and lifecycle [2]. Deepening Health Insurance Reform - Development of commercial medical insurance is encouraged, with a focus on creating a comprehensive product system that includes new medical technologies and treatments [3]. - The guidelines support the growth of long-term care insurance and income loss insurance due to disability, integrating cash benefits with care services [3]. - Disease insurance will be developed steadily, with regular updates to disease definitions and incidence rates [4]. - A new health service guarantee system will be established, integrating prevention, management, and protection [4]. - Collaboration between health insurance and the broader health industry is promoted to enhance service networks and support the development of the health sector [4]. Enhancing Sustainable Development Capacity - The guidelines call for strengthening professional capabilities within insurance companies and improving actuarial practices [6]. - Emphasis is placed on advancing digital transformation in health insurance, utilizing AI and big data to enhance operational efficiency and customer satisfaction [7]. - Health insurance companies are encouraged to explore innovative business models that integrate health management with insurance products [7]. Strengthening Health Insurance Regulation - A robust regulatory framework will be established, including independent financial rules and product oversight to ensure compliance and fair pricing [8]. - The guidelines aim to improve market order by enhancing performance management and addressing consumer complaints effectively [8]. - Strict measures will be taken against illegal activities within the insurance market to maintain order and mitigate risks [8]. Optimizing the Health Insurance Development Environment - The establishment of industry standards and simplified insurance terms is prioritized to enhance clarity and accessibility for consumers [9]. - Collaboration among regulatory bodies, industry organizations, and local governments is encouraged to support the development of tailored health insurance products [9]. - Efforts will be made to increase public awareness and understanding of health insurance through educational initiatives [9].

Core Insights - The Financial Regulatory Bureau issued guidelines to promote high-quality development in health insurance, emphasizing the need for innovation in products like personal account-based long-term medical insurance and dividend-based long-term health insurance [2][3] Background - Health insurance is crucial for providing financial protection against health-related losses, linking to the broader social security network and the health of the nation [3] - The increasing demand for health insurance is driven by economic development and the Health China strategy, highlighting its growing importance [3] - Current challenges in the health insurance sector include product homogeneity, insufficient industry capabilities, and inadequate collaboration with the medical sector [3] Development Directions - The guidelines outline key development areas for major health insurance types, including commercial medical insurance, long-term care insurance, income loss insurance due to disability, and disease insurance [3][4] - For commercial medical insurance, the guidelines advocate for a comprehensive product system, inclusion of new medical technologies, and a fair pricing mechanism [4] - Long-term care insurance is encouraged to align with community and institutional care needs, offering cash benefits alongside care services [5] - Disease insurance is to be developed steadily, with regular updates to disease definitions and incidence rates [5][6] Innovation Initiatives - The guidelines support the introduction of dividend-based long-term health insurance for well-rated insurance companies [7] - A new health service guarantee system is proposed, integrating prevention, management, and post-care services [7] - Collaboration between insurance companies and pharmaceutical firms is encouraged to explore innovative payment methods based on market principles [7][8] Market Opportunities - In 2024, the total premium income for short-term and long-term commercial health insurance in China is projected to reach 977.3 billion yuan, with significant room for growth in meeting customer needs [9] - The guidelines set a 2030 target for health insurance to play a more significant role in the national health security system, promoting a multi-layered market structure [9] Strategic Recommendations - Insurance companies are advised to focus on product innovation, industry collaboration, technology empowerment, and leveraging policy benefits to drive sustainable growth [10] - Emphasis on differentiated product offerings targeting specific demographics, such as those with pre-existing conditions and the elderly, is recommended [10][11] - Companies should enhance their integration with healthcare services and pharmaceutical innovations, creating a comprehensive health management service [10][11]

Core Viewpoint - The "Guiding Opinions on Promoting the High-Quality Development of Health Insurance" issued by the Financial Regulatory Bureau emphasizes the significant role of health insurance in the national health security system by 2030, outlining development goals and innovative points for the industry [1][2]. Summary by Sections Development Goals - By 2030, health insurance is expected to play a crucial role in the national health security system, with a multi-level health insurance market structure that meets diverse needs across the entire population and lifecycle [2]. - The regulatory framework for health insurance will be more robust, enhancing regulatory effectiveness [2]. Industry Challenges - Despite rapid growth, the health insurance sector faces challenges such as product homogeneity, insufficient operational capacity, and inadequate collaboration with the medical and pharmaceutical sectors [2][5]. - The need for innovation is highlighted as a key factor for the high-quality development of commercial health insurance [2]. Innovative Products - The introduction of personal account-based long-term medical insurance and dividend health insurance is a significant innovation, allowing for a richer service offering and aligning with the trend of integrating health insurance with health management [3][4]. - The personal account model is expected to function alongside primary medical insurance, enabling investment returns and covering health management expenses [3]. Regulatory Support - The Opinions support well-rated insurance companies in launching dividend-based long-term health insurance, expanding the sources of returns beyond fixed income [4]. - The cap on health management costs in net premiums is set to increase for certain health insurance companies, allowing them to develop unique offerings [4]. Integration with Innovative Medical Solutions - The Opinions stress the importance of integrating new medical technologies, drugs, and devices into insurance coverage, promoting collaboration with pharmaceutical companies for innovative payment methods [5]. - The commercial health insurance sector is increasingly recognized for its role in facilitating access to high-cost treatments, such as CAR-T therapy, which are not covered by national insurance [6]. Future Directions - The Financial Regulatory Bureau plans to enhance communication with other departments to create a favorable policy environment for health insurance development and to implement detailed regulations for floating yield health insurance [6].